Heterogeneous RNA editing and influence of ADAR2 on mesothelioma chemoresistance and the tumor microenvironment.
Hariharan A, Qi W, Rehrauer H, Wu L, Ronner M, Wipplinger M, Kresoja-Rakic J, Sun S, Oton-Gonzalez L, Sculco M, Serre-Beinier V, Meiller C, Blanquart C, Fonteneau JF, Vrugt B, Ruschoff JH, Opitz I, Jean D, de Perrot M, Felley-Bosco E
Mol Oncol. 2022 Dec;16(22):3949-3974. doi: 10.1002/1878-0261.13322. Epub 2022 Oct 31.
(Link opens in a new window)
PubMed
(Link opens in a new window)
Article
Plasmids from Article
| ID | Plasmid | Purpose |
|---|---|---|
| 158112 | pSpCas9_human_ADAR2_ccC | deletion hADAR2 |
| 158113 | pSpCas9_human_ADAR2_ccB | deletion hADAR2 |
| 158114 | pSpCas9_human_ADAR2_ccA | deletion hADAR2 |
| 158117 | pSpCas9_mouse_Adar2_ccC | deletion mADAR2 |
| 158118 | pSpCas9_mouse_Adar2_ccA | deletion mADAR2 |
| 158119 | pSpCas9_mouse_Adar2_ccB | deletion mADAR2 |
| 175588 | BII-ChBtW-mADAR2-short | mammalian expression of mouse short Adar2, blasticidine selection |